[This Week's IPO] October Second Week Demand Forecast and Subscription Schedule
In the second week of this month (October), Eugene Technology and Seoul Guarantee Insurance will begin demand forecasting for institutional investors. Shinseong ST and SLS Bio will conduct general subscriptions.
◆Eugene Technology= Established in 2010, Eugene Technology is primarily engaged in secondary battery precision molds, precision machine parts, automation equipment, and lead tabs. The sales proportion by product category is approximately 74% for precision molds such as notching molds and forming molds, about 22% for precision machine parts such as friction shafts, knife units, and lamicutters, and about 4% for other items including lead tabs.
The total number of shares offered is 1,049,482, with a desired public offering price per share of 12,800 to 14,500 KRW. The company plans to raise approximately 15.2 billion KRW (based on the upper limit of the desired price band) through this offering. Demand forecasting for institutional investors will be conducted from the 11th to the 17th, after which the public offering price will be finalized. General subscriptions will be accepted from the 23rd to the 24th of the same month. The company aims to be listed in early November, with NH Investment & Securities as the lead underwriter.
◆Seoul Guarantee Insurance= Established in 1969, Seoul Guarantee Insurance is the largest comprehensive guarantee company in South Korea, providing various products including performance guarantees, identity guarantees, mobile phone installment guarantees, mid-interest loan guarantees, and jeonse deposit loan guarantees. It is a member of ICISA (International Credit Insurance & Surety Association) and ranks among the global top 4 guarantee companies based on gross written premiums.
The total number of shares offered is 6,982,160, all of which are existing shares for sale. The desired public offering price per share is 39,500 to 51,800 KRW, with the offering size ranging from 275.8 billion to 361.7 billion KRW. Demand forecasting will be conducted from the 13th to the 19th, followed by general subscriptions on the 25th and 26th. The lead underwriters are Mirae Asset Securities and Samsung Securities.
◆Shinseong ST= Shinseong ST finalized its public offering price at 26,000 KRW, exceeding the upper limit of the desired price band. The total offering amount is 52 billion KRW, making it the largest KOSDAQ public offering since July this year. A total of 1,967 domestic and international companies participated, recording a competition rate of 583.5 to 1. General subscription for individual investors will be conducted through Mirae Asset Securities from the 10th to the 11th, with the expected listing date on the 19th.
Shinseong ST manufactures key components for electric vehicle (EV) and energy storage system (ESS) batteries. Its main products include conductive busbars that connect the current of electronic components within secondary battery cells and module cases that protect secondary battery cells from external shocks.
◆SLS Bio= SLS Bio finalized its public offering price at 7,000 KRW, below the lower limit of the desired price band. A total of 640 domestic and international institutions participated in the demand forecasting, recording a competition rate of 235.14 to 1. The offering amount is 5.4 billion KRW. General subscriptions will be conducted from the 10th to the 11th, with Hana Securities as the lead underwriter.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
SLS Bio is a bio-venture company established in 2007 and listed on the KONEX market in 2016. Its headquarters is located in Gwanggyo, Suwon, with a production plant in Yongin. Its main business areas include ▲ the core cash cow business of 'pharmaceutical quality control' ▲ the strategic new business of 'new drug development support' ▲ research, development, and sales of in vitro diagnostic devices for humans and animals based on proprietary NTMD and NALF platform technologies.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.